Comparison of oximetry methods reveals negligible bias in oxygen extraction fraction for sickle cell patients, indicating reliability.
Motivation: OEF as a biomarker requires SvO2 quantity, which can be estimated via susceptometry-based oximetry (SBO) and T2-based oximetry (T2O). SvO2 presents a 3% bias in T2O relative to SBO in healthy subjects, while OEF between SBO and T2O in adults with sickle cell disease (SCD) still needs investigation. Goal(s): Our goal was to evaluate the systemic bias of SvO2-dependent quantities between SBO and T2O in adults with SCD. Approach: In this study, OxFlow and TRUST sequences were conducted for SvO2 estimation. Results: SBO and T2O yielded a negligible bias in OEF in subjects with SCD. Impact: SBO and T2O are in good agreement in OEF estimation, in excellent consistence with the trend reported for healthy subjects.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: